The same cancer types displayed significant association between PD-L1 expression and ICI therapy response, including GC (p = 1.55e-6), HCC (p = 0.0068), and HNSCC (p = 0.034), and a trend was observed also in MCC (p = 0.15). The gene discussed is CD274; the disease is hepatocellular carcinoma.